Institute for Cellular Medicine, Newcastle University, Newcastle Upon Tyne, UK.
Department of Social Work, Education and Community Wellbeing, Northumbria University, and CRESTA Fatigue Clinic, Newcastle upon Tyne NHS Foundation Trust, UK.
Clin Exp Rheumatol. 2019 May-Jun;37 Suppl 118(3):78-82. Epub 2019 Jul 15.
To characterise the sleep profile of patients with primary Sjögren's syndrome (pSS) and its relationship between hyper-somnolence and other clinical parameters.
In phase one of the study, we utilised cross-sectional data on daytime hyper-somnolence from the United Kingdom Primary Sjögren's Syndrome Registry (UKPSSR) cohort (n=857, female=92.7%). Phase two relied on clinical data from a cohort of patients (n=30) with PSS, utilising symptom assessment questionnaires and sleep diaries.
Within the UKPSSR, daytime hyper-somnolence was prevalent (ESS, 8.2±5.1) amongst pSS patients with a positive correlation between daytime hyper-somnolence and fatigue (Spearman's rs = 0.42, p<0.0001). Amongst the clinical cohort, 100% of patients had problematic sleep. Participants with pSS awoke frequently (NWAK, 2.2±1.3), had difficulty in returning back to sleep (WASO, 59.9±50.2 min vs. normal of <30min) and a reduced sleep efficiency (SE, 65.7±18.5% vs. >85%). Fatigue (FIS, 82.4 ±33.5) and orthostatic symptoms (OGS, 6.7 ±3.7) remained high in these patients.
Sleep disturbances are a problem in pSS, comprising difficulty in maintaining sleep, frequent awakenings throughout the night and difficulties in returning back to sleep. As such, the total time in bed without sleep is much greater and sleep efficiency greatly reduced. These patients in addition have a high symptomatic burden possibly contributing to and/or contributed by poor and disordered sleep.
描述原发性干燥综合征(pSS)患者的睡眠特征及其与过度嗜睡之间的关系。
在研究的第一阶段,我们利用了英国原发性干燥综合征登记处(UKPSSR)队列的日间过度嗜睡的横断面数据(n=857,女性=92.7%)。第二阶段依赖于 30 名 pSS 患者的队列的临床数据,使用症状评估问卷和睡眠日记。
在 UKPSSR 中,日间过度嗜睡在 pSS 患者中较为常见(ESS,8.2±5.1),且日间过度嗜睡与疲劳之间存在正相关(Spearman's rs=0.42,p<0.0001)。在临床队列中,100%的患者存在睡眠问题。pSS 患者经常醒来(NWAK,2.2±1.3),难以重新入睡(WASO,59.9±50.2 分钟与<30 分钟的正常情况相比),睡眠效率降低(SE,65.7±18.5%与>85%相比)。这些患者的疲劳(FIS,82.4 ±33.5)和直立症状(OGS,6.7 ±3.7)仍然很高。
睡眠障碍是 pSS 的一个问题,包括难以维持睡眠、夜间频繁醒来以及难以重新入睡。因此,没有睡眠的总卧床时间要长得多,睡眠效率大大降低。这些患者的症状负担很高,可能是由于睡眠不佳和睡眠紊乱,也可能是由睡眠不佳和睡眠紊乱引起的。